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Hepatic disease is often treatable and has a predictable prognosis when a deﬁnitive diagnosis is made. The aim of
clinicopathological evaluation of hepatobiliary aﬀections is to identify and characterize hepatic damage and dysfunction, identify
possible primary causes of secondary liver disease, diﬀerentiate causes of icterus, evaluate potential anaesthetic risks, assess
prognosis and response to xenobiotics, and monitor response to therapy. This paper describes the diﬀerent diagnostic methods
and imaging techniques employed in diagnosis of hepatobiliary aﬀections in dogs. Besides reviewing the signiﬁcant clinical
manifestations and imaging structural abnormalities in diagnostic approach to diﬀerent hepatic aﬀections, it also depicts
radiographic, ultrasonographic, and wherever applicable, the laparoscopic characterization of diﬀerent hepatic aﬀections and
target lesions encountered in clinical cases presented in the Teaching Veterinary Clinical Complex, COVAS, Palampur in the year
2007-2008.
1.Introduction
Hepatic aﬀections in the dog are associated with varied
and often vague clinical signs and thus frequently present
a diagnostic challenge to veterinary practitioners. As the
liver has great functional reserve capacity, detection of the
hepatic functional impairment by conventional means is
only possible once a signiﬁcant hepatic dysfunction (≥55%)
is present [1]. Furthermore, systemic diseases and various
drugs can cause misleading increases in serum activities
(secondary or reactive hepatopathies), and it can be a clinical
dilemma to decide whether liver enzyme elevations are
signiﬁcant,andwhethertheyrepresentprimaryorsecondary
liver disease [2]. Despite availability of a range of diagnostic
tests of both hepatic damage and dysfunction, there is rarely
a single test that adequately identiﬁes hepatic disease or its
underlying cause.
The role of survey radiography in detecting the alteration
in liver size has been widely emphasized. But with the
advent of time, ultrasonography evolved as the paramount
technique of diagnostic imaging. The desirable virtues of
less time consumption and noninvasive assessment of the
detailed internal architecture of the liver and the adjacent
structures, including the portal vein, established ultrasonog-
raphy as the choicest technology, for identifying the various
formsofhepaticdiseaseincanines[2].Presently,laparoscopy
is also emerging as a fruitful imaging modality. It oﬀers
tremendous advantage of direct visceral visual inspection of
liver and allows its descriptive or photographic documenta-
tion. This technique provides three-dimensional evaluations
of liver and is also a minimal invasive method to obtain
cytology, biopsy, and cultural samples from focal lesions or
generalized disease condition/carcinomatous growth of liver
[3].
It is important to interpret all results in light of the
otheraspectsofthediagnosticinvestigation, inparticularthe
history and physical examination. In most cases, a tentative
diagnosis of primary hepatic disease can be deduced by cor-
relating the ultrasonographic abnormalities with the history,
physical examination ﬁndings, clinical laboratory results,
and radiographic/laparoscopic observations. However, for
identiﬁcation of speciﬁc hepatopathies and thus establish-
ment of deﬁnitive diagnosis of primary liver disease, the
histopathological examination of the liver biopsy specimens
is usually required.2 Veterinary Medicine International
2. Diagnostic Tests and Imaging Techniques for
the HepatobiliaryAffections
By using a combination of history, physical examination
ﬁndings, results of screening, and hepatobiliary-speciﬁc
laboratory tests, the clinician usuallybecomes apt to describe
the disorder as active or quiescent. Also, it becomes easy
for him/her to characterize the pattern of hepatobiliary
disease (primarily hepatocellular, primary biliary, or mixed
hepatobiliary) and further estimate the degree of hepatobil-
iary dysfunction [2]. So in the light of all these aspects, a
complete evaluation comprising of the following tests, must
be conducted.
2.1. Laboratory Evaluation Tests
2.1.1. Complete Blood Count. T h ec o m p l e t eb l o o dc o u n t
(CBC) is an integral part of the diagnostic investigation of
any systemic disease process or for that matter of hepatic
aﬀections.Itconsistsofquantitativeandqualitativeexamina-
tion. The quantitative examination includes packed cell vol-
ume (PCV), total red blood cell count (RBC), haemoglobin
(Hb) concentration, total white blood cell count (WBC),
diﬀerential WBC count and platelet count. In addition, the
redcellmeancorpuscularvolume(MCV),meancorpuscular
haemoglobin (MCH), and mean corpuscular haemoglobin
concentration (MCHC) are also evaluated. The qualitative
examination includes examination of blood smears for
changes in cellular morphology.
2.1.2. Serum Biochemistry. Biochemical ﬁndings often prove
to be the most useful aid in the diagnosis of hepatobil-
iary aﬀections. Liver-speciﬁc serum enzyme activities are
included routinely in screening serum biochemistry panels
and are regarded as markers of hepatocellular and biliary
injury and reactivity [2]. In addition to this, many biochem-
ical tests are not speciﬁc indicators of liver disease, but do
oﬀer a crude assessment of liver status, or aid recognition of
diseases that either mimic the clinical signs of liver disease
or actually cause secondary liver disease. The minimum
serum biochemical database comprises of ALT, AST, ALP,
GGT, BUN, creatinine, total bilirubin, total protein, glucose,
albumin, globulin, and cholesterol in suspected hepatic
aﬀections [1].
2.1.3. Urinalysis and Faecal Analysis. Urine analysis provides
rapid and valuable information about the urinary tract and
other body systems including liver. A complete urine analysis
(including dipstick, speciﬁc gravity (SG), and sediment
examination) is often required, even if one component part
shows no abnormalities [2]. Concurrent serum biochemical
analysis, although, is often required to gain maximum
beneﬁt from urine analysis. There is deﬁnite change in the
appearance of the faeces in hepatobiliary aﬀections. So, the
faecal specimen analysis must be conducted although it
rarely provides useful information in the evaluation of the
dog with suspected hepatobiliary aﬀection.
Figure 1: Six-year-old neutered male Labrador Retriever dog posi-
tioned in left lateral recumbency for ultrasound-guided abdom-
inocentesis. The needle is directed perpendicular to the abdominal
wall, with care taken to avoid the spleen.
Figure 2: Two-dimensional ultrasonographic appearance of 22-
gauge needle as hyperechoic structure within the textured abdom-
inal eﬀusion in 6-year-old male Labrador Retriever aﬀected with
infectious peritonitis.
2.1.4. Abdominocentesis. Analysis of abdominal eﬀusions is
an important component of diagnosis. It can either assist
in timely identifying the pathological process responsible for
the ﬂuid accumulation or it can help in indicating further
investigative procedures which may be helpful in diagnosing
the aﬀection [4]. Abdominocentesis can be performed with
the patient standing or in left lateral recumbency either with
blind percutaneous abdominocentesis or with ultrasound-
guided abdominocentesis (Figures 1 and 2). The abdominal
eﬀusion so obtained is analysed by subjecting it to gross
examination, cytological examination, and microbiological
examination. Besides, total protein concentration and total
nucleated cell count is also evaluated [2]. The eﬀusion
analysedisthenclassiﬁedastransudate,modiﬁedtransudate,
or exudates (Figure 3).
2.1.5. Coagulation Tests. T h el i v e rp l a y sac e n t r a lr o l e
in the coagulation and ﬁbrinolytic systems, and subtle
abnormalities may be detected by assay of individual factor
activities. Whilst a bleeding diathesis will be expected if
there is a history of gastrointestinal bleeding, an occult
tendency should always be suspected, and a clotting proﬁle
is mandatory before a liver biopsy is performed [3]. The
coagulation proﬁle should comprise evaluation of buccalVeterinary Medicine International 3
Figure 3: Gross appearance of the abdominal eﬀusion (septic
exudate)obtainedunderultrasoundguidancefrom6-year-oldmale
Labrador Retriever aﬀected with infectious peritonitis.
Figure 4: Left lateral capnoperitoneograph enhancing visualization
of right liver lobes and diaphragmatic border in 8-year-old
male Dobermann Pinscher dog demonstrating classical signs of
pulmonary metastasis with strong suspicion for hepatic neoplasia.
mucosal bleeding time, whole blood clotting time, one-
stage prothrombin time (OSPT or PT), and activated partial
thromboplastin time (aPTT). In conjunction to it, an
assessmentofﬁbrindegradationproducts(FDPs),D-dimers,
and vitamin-K should also be made [2].
2.1.6. Dynamic Liver Function Tests. These tests can be very
useful in diagnosing hepatic aﬀections, with the exception of
those patients, who are icteric. These tests rely on analysis of
pairedbloodsamplestoassessthecapacityofthelivertoclear
endogenous (bile acids and ammonia) or exogenous (bro-
mosulphthalein and indocyanine green) substances from
the circulation [2]. Impaired clearance although suggests
hepatocellular dysfunction and/or portosystemic shunting,
but does not diﬀerentiate the cause. Therefore, additional
tests, including portovenography, ultrasonography, and liver
biopsy are required [2].
2.2. Radiography. Survey abdominal radiographs (lateral
and ventrodorsal view) are useful to evaluate the morpho-
logic abnormalities in size, shape, position, and density
(mineralization/radiolucencies) of the liver and presence of
abdominal eﬀusion. However, lack of abdominal contrast
and insensitivity to detect subtle changes limits the precision
of abdominal radiography. It is diﬃcult to evaluate the entire
Figure 5: Right lateral capnoperitoneograph enhancing visualiza-
tion of left liver lobes and diaphragmatic border in 8-year-old
male Dobermann Pinscher dog demonstrating classical signs of
pulmonary metastasis with strong suspicion for hepatic neoplasia.
Figure 6: Grasping of jejunal loop under laparoscopic-guidance for
performing laparoscopic guided and laparotomy assisted introper-
ative mesenteric portography in 1-year-old male mixed breed dog
with progressive weakness.
liver as much of the liver is silhouetted by the diaphragm,
stomach and right kidney [5]. Capnoperitoneography, the
special contrast radiographic procedure, enhances the vis-
ceral visualization of abdominal organs in general and is
very useful in the evaluation of liver lobes and its borders,
especially the diaphragmatic border [6, 7] (Figures 4 and
5). In suspected cases of hepatic neoplasia, thoracic ﬁlms to
evaluate the pulmonary metastasis are also desired.
In addition to these, laparoscopic-guided intraoperative
mesenteric portography (Figures 6, 7,a n d8) and/or ultra-
sound-guided percutaneous splenoportography (Figures 9
and 10) are easily executable procedures to evaluate the
hepatic blood ﬂow in clinical settings.
2.3.Ultrasonography. Ultrasonographyisanexcellentnonin-
vasivewaytoevaluateliverparenchyma.Itisparticularlyuse-
ful in diﬀerentiating focal from diﬀu s ed i s e a s e ,c y s t i cf r o m
solidmassesandobstructivefromnonobstructiveicterus[5].
Indications for hepatic ultrasound usually include elevated
liver enzymes and presence of free abdominal eﬀusion. This
procedure is also indicated for determining the extent of
abdominal metastasis in cases of hepatic neoplasia and to
image congenital or acquired portocaval or portosystemic
shunts. Doppler imaging conﬁrms the location of the4 Veterinary Medicine International
Figure 7: Laparotomy-assisted exteriorization of jejunal loop and
catheterization of jejunal vein and rapid infusion of positive
contrast agent (Urograﬁn 76%) in 1-year-old male mixed-breed
dog, suspected for portosystemic shunting.
Figure 8: Normal-appearing hepatic angiogram, demonstrating
jejunal mesenteric vein normally draining into the portal vein and
the extensive portal vein branches in1-year-old male mixed-breed
dog.
suspicious vessels and direction of the blood ﬂow within
and can also provide supportive evidence of intrahepatic
portal hypertension by allowing the assessment of the speed
and direction of portal ﬂow [2]. Besides, ultrasound-guided
percutaneous hepatic biopsy allows precise direction of the
biopsy needle to the area of abdominal tissue while avoiding
large vessels, the gall bladder, and the gastrointestinal tract
[5].
2.4. Laparoscopy. Laparoscopy oﬀers tremendous advantage
of direct visceral visualization (three-dimensional) of the
liver and adjacent structures such as the pancreas and
extrahepatic biliary tract. Laparoscopy may reveal very
small (0.5cm or less) metastatic lesions that are not easily
observed by other diagnostic techniques. Laparoscopy may
alsoprovideaccurate,deﬁnitiveandstaginginformationthat
otherwise would have been obtained only through a surgical
laparotomy. It also provides minimal invasive method to
obtain cytology, biopsy, and culturalsamples fromfocalhep-
atic lesions or generalized disease condition/carcinomatous
growth [3]. It is seen that laparoscopy provides better
liver biopsy tissues than any other traditional percutaneous
methodsespeciallywhentheliverissmall[1].Italsoprovides
the advantage of procuring biopsy from areas visually that
Figure 9: Ultrasound-guided percutaneous injection of positive
contrast agent (Urograﬁn 76%) in 3-year-old male Labrador Re-
triever dog, suspected for portosystemic shunting.
Figure 10: Ultrasound-guided percutaneous normal-appearing
splenic portogram demonstrating splenic vein normally draining
into portal vein with hepatic contrast opaciﬁcation in 3-year-old
male Labrador Retriever dog.
are less vascular and to monitor the extent of bleeding after
a biopsy [3]. It is preferred to percutaneous techniques
when excess bleeding is expected and to laparotomy when
delayed wound healing (hypoalbuminaemia) is anticipated.
The minimal invasiveness of the procedure, rapid patient
recovery, and diagnostic accuracy make laparoscopy an ideal
technique compared with more invasive procedures. Despite
the advent of newer laboratory tests, imaging techniques,
and ultrasound-directed ﬁne-needle biopsy or aspiration,
laparoscopy remains a valuable tool when appropriately
applied in a diagnostic plan. Ascites, abnormal clotting
times, small body size (<2kg of body weight), and poor
patient condition are the only relative contraindications
to laparoscopy. This technique requires heavy sedation or
anaesthesia and is subject to equipment availability and
clinician expertise.
2.5. Scintigraphy, Magnetic Resonance Imaging (MRI), and
Computed Tomography. Scintigraphy (nuclear imaging),
magnetic resonance imaging (MRI), and computed tomog-
raphy have recently been used in the diagnosis of hepatobil-
iary aﬀections, but the need for radioisotopes and expensive
equipmenthasrestrictedtheirusetotheteachinginstitutions
of developed nations. Of these three imaging modalities,
scintigraphy has been thoroughly evaluated for diagnosisVeterinary Medicine International 5
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Figure 11: Laparoscopic-guided percutaneous Tru-Cut needle biopsy of hepatic mass in 8-year-old intact male Labrador Retriever dog.
of hepatobiliary aﬀections in canines [2]. It employs the
use of isotope technetium 99m (
99mTc), which is incorpo-
rated into the radiopharmaceutical speciﬁc for the planned
study.Afteranintravenousinjectionofradiopharmaceutical,
scintigraphic images are made sequentially over 3 hours
to determine whether isotope has been taken up by the
liver, excreted into the biliary tract, and expelled into the
intestine. In canines with extrahepatic bile duct obstruction,
no evidence of radiopharmaceutical is detected in the gall
bladder or intestine. Another application of scintigraphy is
used in the diagnosis of PSS in canines.
2.6. Liver Biopsy and Histopathological Examination. Liver
biopsy is often required to deﬁnitely characterize the nature
and severity of the hepatic disease. It can be further used to
diﬀerentiateacutefromchronicdisorders,tostageneoplastic
diseaseandtoassessresponsetotherapy.Selectionofthebest
procedure for obtaining a liver biopsy depends on numerous
factors including liver size, presence of coagulopathy, any
focal or diﬀuse lesion, presence of biliary tract obstruction,
or any other intra-abdominal abnormalities. The selection
of the biopsy method also depends on likelihood of sur-
gical resection of a mass, tolerance of general anaesthesia,
available equipment and expertise of the clinician [2]. The
various biopsy methods include ﬁne-needle aspiration, blind
percutaneous needle biopsy using Tru-Cut biopsy needle,
ultrasound-guided needle biopsy, keyhole needle biopsy, and
laparoscopic-guided biopsy [8] (Figures 11, 12, 13,a n d
14). The biopsy specimens so procured are subjected to
standardized processing and histopathological examination
for yielding deﬁnitive diagnosis of hepatic aﬀections.
3. Diagnostic Features/Alterations in Different
HepatobiliaryAffections
The following canine hepatopathies have been reviewed
according to their prevalence in clinical practice.
3.1. Chronic Hepatitis
3.1.1. Etiology. In idiopathic chronic hepatitis, it is probable
that after an initial inciting hepatocyte injury, immune
Figure 12: Laparoscopic procurement of liver biopsy (right ﬂank
approach) depicting oval biopsy forceps grasping the hepatic nod-
ule at the edge of right medial liver lobe in 7-year-old male mixed-
breed dog with hepatic nodular hyperplasia and radiographic
appreciation of pulmonary metastasis.
mechanisms are involved in perpetuating the inﬂamma-
tion [8]. Familial chronic hepatitis in Bedlington terri-
ers, Dobermann pinschers, West Highland White Terriers
and Skye Terriers have a hereditary (autosomal recessive)
inability to excrete copper in the bile that is associated
with progressive hepatic copper accumulation and chronic
liver disease [9]. Chronic drug administration (heart-
worm preventatives, anticonvulsants, glucocorticoids, and
chemotherapeutic drugs) is a frequent cause of chronic
hepatitis in canines [8]. Latent hepatic viral infection with
canine adenovirus type I, which is responsible for infectious
canine hepatitis (ICH), is also suspected to cause persistent
inﬂammation and thus chronic hepatitis [9]. Cirrhosis is the
irreversible end stage of the chronic hepatic injury caused
by the infection, hepatotoxins (copper and anticonvulsants),
immunologic injury (chronic hepatitis), chronic cholestasis,
and hypoxia [9]. Hepatic inﬂammation, regeneration and
ﬁbrosis result in the development of portal hypertension
andtheestablishmentofmultipleextrahepaticportosystemic
shunts which in turn promote the development of ascites
[1, 8], whereas perihepatic changes such as ascites, portal
and splenic vein dilation and splenomegaly might occur with
cirrhosis because of portal hypertension [10].6 Veterinary Medicine International
Figure 13: Laparoscopic postprocurement monitoring of liver
biopsy site for bleeding in 7-year-old male mixed-breed dog with
hepatic nodular hyperplasia.
3.1.2. Clinical Manifestations. Dogs aﬀected by this condi-
tion are mostly young or middle aged adults of either sex
with signs of hepatitis of varying severity. The symptoms
included lethargy, depression, weight loss, vomiting, and
jaundice. Idiopathic chronic hepatitis, however, appears to
be highest in female dogs with signs of anorexia, depression,
weakness, polyuria/polydipsia, ascites, jaundice, weight loss,
and vomiting [9]. The physical examination ﬁndings with
copper-associated acute hepatitis may include depression,
lethargy, dehydration, jaundice, and hepatomegaly. With
end-stage hepatic disease, the signs included dehydration,
emaciation/musclewasting,ascites,andabnormalmentation
(hepatic encephalopathy) with jaundice and a nonpalpable
small liver [9]( Figure 15).
3.1.3. Laboratory Evaluation. Erythrocytic morphologic
changes which include variable red cell shapes (poikilocytes)
with irregularly speculated erythrocytes (acanthocytes or
spur cells) and target cells are considered to be consistent
with chronic hepatobiliary disease [9]. An inﬂammatory leu-
cogram is also sometimes seen in severe chronic inﬂamma-
tory hepatopathies [8]. Consistent serum chemistry ﬁndings
include increased ALT and ALP activity reﬂecting ongoing
hepatic injury and intrahepatic cholestasis respectively,
whereas less consistent ﬁndings include hypoalbuminaemia,
hyperglobulinaemia, and abnormal haemostasis [9]. Ascitic
ﬂuid, when present, typically is a transudate or modiﬁed
transudate [1].
3.1.4. Radiographic Features. Radiographic appearance of
cirrhosedlivervarieswiththestageandseverityofthedisease
andasmall,denseliverwithanirregularnodularsurfacemay
beidentiﬁed(withorwithoutpneumoperitoneograph)most
commonly in cirrhosis [7]. However, radiographic appreci-
ation of reduced liver size (microhepatica) is more diﬃcult
than hepatomegaly [11]( Figure 16). The abdominal eﬀusion
in ascitic dogs precludes the radiographic examination of the
liver and other abdominal organs with its classic “ground
glass” appearance (Figure 17).
3.1.5. Ultrasonographic Features. Sonographic features in
cases of cirrhosis vary from multiple hepatic nodules (from
Figure 14: Laparoscopic Procurement of 3mm liver tissue in 7-
year-old male mixed-breed dog with hepatic nodular hyperplasia.
Figure 15: 4-year-old male mixed-breed dog with chronic hepatitis
manifestingsevereabdominalenlargement(ascites)duringphysical
examination.
macronodular regeneration) besides hyperechoic hepatic
parenchyma and decreased liver lobe size [12]t od i ﬀuse
hyperechoic (bright) but small liver with distended gall
bladder and irregular contour [13, 14]. Cirrhosis can be
visualized sonographically as increased hepatic echogenicity
accompanied with less distinct appearance of the echogenic
portal vein margins and decreased distal visualization. This
speciﬁc ultrasonographic ﬁnding is because of increased
beam attenuation. Periportal ﬁbrosis in cirrhotic liver is
suggested by abnormally heterogenous hepatic echogenicity
giving it a mottled appearance and abnormally prominent
marginal echoes of the intrahepatic branches of the portal
vein [15]. Increase in hepatic echogenicity may be present
in disease conditions like cirrhosis, hepatic lipidosis, steroid
hepatopathy, lymphosarcoma, long-term cholangiohepatitis,
and some toxic hepatopathies [16, 17] (Figures 18 and 19).
3.1.6. Histopathological Features. The primary lesion is
portal inﬂammation consisting primarily of lymphocytes
and plasma cells; occasional neutrophils and macrophages
[8]. With idiopathic chronic hepatitis, the inﬂammation
extends into the hepatic lobule, causing piecemeal necrosis
of hepatocytes [9]. In familial chronic hepatitis, H and E-
stained hepatic tissue reveals dark granules in hepatocyte
cytoplasmincentrilobularhepatocytesintheearlystagesand
generalized in later stages [9]. Microscopic features includeVeterinary Medicine International 7
Figure 16: Right lateral radiograph of a 2-year-old castrated male
mixed-breed dog with microhepatica. The stomach is distended
with gas, which provides contrast with the liver shadow. Notice
the proximity of the stomach to the diaphragm, implying reduced
hepatic mass.
Figure 17: Lateral standing abdominal radiograph of a 7-year-old
male mixed-breed ascitic dog with classic “ground glass appear-
ance” of abdomen and masking of abdominal cavity details.
ﬁbrosis, regenerative nodules, and disruption of normal
hepatic architecture.
3.2. Noncirrhotic Portal Hypertension. Three unusual dis-
eases of primarily young dogs, that is, hepatoportal ﬁbrosis,
idiopathic hepatic ﬁbrosis, and primary hypoplasia of portal
vein might be grouped under this title.
3.2.1. Etiology. Portal hypertension can have prehepatic
causes such as portal vein thrombosis, stenosis, or compres-
sion by enlarged portal lymph nodes/neoplastic masses. Pos-
thepatic causes include compression of hepatic veins, caudal
vena cava, or right heart disease [18]. Portal hypertension
may be secondary manifestation of right-sided congestive
heart failure, caudal vena cava obstruction, and intrahepatic
obstruction [19].
3.2.2. Clinical Manifestations. Most aﬀected dogs are pre-
sented as young or middle aged dogs (≤2.5 years) of
either sex with signs of hepatic failure including lethargy,
depression, weight loss, jaundice, and ascites [9]. Abnormal
mentation due to hepatic encephalopathy may be a less
consistent sign of this disorder [8].
Figure 18: Ultrasonograph (2D) in sagittal scan of shrunk liver
with hyperechoic hepatic parenchyma and irregular lobe margins
surroundedwithanechoicabdominaleﬀusionina5-year-oldintact
male Cocker spaniel dog.
Figure 19:Sonograph(2D)intransversescanshowinghyperechoic
liver lobe and cholecystitis with inspissated bile in gall bladder (GB)
in a 7-year-old intact Pomeranian male dog.
3.2.3. Laboratory Evaluation. Microcytosis is a common
feature with this disorder. Noncirrhotic portal hypertension
disorders are characterized paradoxically by abnormal liver
enzyme activities and hyperbilirubinemia in about 50% of
the cases [9].
3.2.4. Radiographic Features. The abdominal eﬀusion pre-
cludes the radiographic examination of the liver and other
abdominal organs as ascites is always a feature with noncir-
rhotic hypertension [9].
3.2.5. Sonographic Features. Portal hypertension is diﬃcult
to diagnose with standard ultrasound imaging. Besides the
presence of multiple portosystemic collateral vessels, ascites,
splenomegaly, and an abnormal liver echogenicity, enlarged
main portal and extrahepatic portal veins are the associated
features with portal hypertension [20]. Ultrasonography is
an eﬀective tool for evaluation of the presence of portal
hypertension and assessment of its eﬀects [18] (Figures 20
and 21).
3.2.6. Histopathological Features. The liver biopsy ﬁndings
and histopathological examination may range from unre-
markable to minimal inﬂammatory changes in disorders of
non-cirrhotic portal hypertension [9].8 Veterinary Medicine International
Figure 20: Dorsal sonogram (2D) of liver depicting hypoechoic
parenchyma with portal vessel dilatation in one-year-old mixed-
breed dog.
3.3. Congenital Portovascular Anomalies
3.3.1. Etiology. The most common patterns of portovascular
anomaly are single-extrahepatic communications between
the portal vein or one of the mesenteric veins and the caudal
vena cava or azygos vein in small-breed dogs and patent
ductusvenosusinlarge-breeddogs[9].Hypoplasiaoraplasia
of intrahepatic portal vasculature could complicate any of
these anomalies, but it is rare.
3.3.2. Clinical Manifestations. Age range of aﬀected dogs of
eithersexis2monthsto8years;mostarepresentedwhenless
than 1 year old. The common clinical signs in canines with
single intrahepatic or extrahepatic PSS are those of hepatic
encephalopathy not always related to meal ingestion and/or
gastrointestinal disturbance such as vomiting, diarrhea,
or pica [9]. The presenting complaints are polyuria and
polydipsia, urate urolithiasis, and anaesthetic or sedative
intolerance.Physicalexaminationﬁndingsincludesmallsize,
poor haircoat, and occasional renal enlargement [8]. Ascitis
isseenincanineswithintrahepaticarteriovenousﬁstula.The
clinical ﬁndings in uncomplicated congenital or acquired
portosystemic shunts are unremarkable except for small
body size or weight loss whereas ascites and continuous
murmur over the area of the liver is a consistent ﬁnding
with hepatic arteriovenous ﬁstulas/secondary portosystemic
shunts [9].
3.3.3. Laboratory Evaluation. Clinicopathologic ﬁndings in
over 50% of the aﬀected dogs, regardless of the type
of vascular anomaly, are microcytosis, hypoalbuminaemia,
mild increases in serum ALT and ALP activities, hypocholes-
terolemia, low-BUN content, postchallenge hyperammone-
mia, and normal or high fasting with high postprandial SBA
[9].
3.3.4. Radiographic Features. A small-sized liver is a frequent
radiographic appreciation with any type of vascular anomaly
[8]. To conﬁrm the location of the anomalous vessel,
combinations of ultrasonography, transcolonic scintigraphy,
or contrast portal venography may be needed [9].
Figure 21: Longitudinal sonogram (2D) of liver depicting hypoe-
choic parenchyma with marked portal vessel dilatation (subjective)
in 5-year-old mixed-breed dog with signiﬁcant spleenomegaly.
3.3.5. Ultrasonographic Features. Routine abdominal ultra-
sonography in canines with portovascular anomalies may
demonstrate intrahepatic and extrahepatic shunts with
reduced hepatic volume and urinary calculi [8]. Markedly
increased and abnormally variable portal blood ﬂow velocity
with attenuated intrahepatic portal vessels and localized
dilatation of the intrahepatic portal vein (PV) at the site
of communication with the caudal vena cava (CVC) may
be detected in congenital intrahepatic portosystemic shunts.
Whereas, in congenital extrahepatic portozygos shunt, the
shunting vessel runs roughly parallel to and on the left of
the abdominal caudal vena cava and could be followed to
the diaphragm without communicating with the caudal vena
cava [21].
3.3.6. Histopathological Features. Liver biopsy most con-
sistently reveals hepatocyte atrophy with small or absent
portalveins.Varyingdegreesofsinusoidalcongestion,biliary
hyperplasia, arteriolar proliferation, lipogranulomata, and
increased periportal connective tissue may be seen [8, 9].
3.4. Acute Hepatic Failure
3.4.1. Etiology. Causes of acute hepatic failure in canines
include hepatotoxins, infectious and parasitic agents, and
miscellaneous disorders [8]. Certain environmental toxins
(pesticides, herbicides, cleaning agents and plant toxins),
have inherent ability to cause hepatic injury either by direct
hepatocellular damage or by disturbance of hepatocellular
homeostasis, which results in cell death [9]. In addition to
this, certain antimicrobial drugs (ketoconazole and trime-
thoprim-sulfa), antihelminths (mebendazole, diethylcarba-
mazine-oxybendazole, and thiacetarsamide), inhalation an-
esthetics (halothane and methoxyﬂurane), and analgesics
(acetaminophen, naproxen, phenylbutazone) have also been
reported to be hepatotoxic in canines [8, 9]. The var-
ious infectious causes of acute hepatic failure include
leptospirosis, toxoplasmosis, histoplasmosis, and infectious
canine hepatitis. Besides, other systemic conditions like
immune-mediated haemolytic anaemia, surgical hypoten-
sion, hypoxia, shock, acute pancreatitis, and extrahepaticVeterinary Medicine International 9
bacterial infections (pneumonia, pyometra, peritonitis, and
abscesses) can also cause severe hepatic injury [8].
3.4.2. Clinical Manifestations. Nutritional status and gender
are important host factors with females being more suscep-
tible to toxic liver injury than males [9]. Dose, duration of
exposure, and chemical composition of the agent contribute
to how toxicity is expressed by the host. The clinical signs
and clinicopathologic features of acute toxic hepatopathy are
not distinct from other hepatopathies except in onset and
perhaps in severity. Vomiting is a consistent sign with acute
toxic hepatopathy. Hepatodynia is a feature with any cause of
acute hepatic injury, whereas fever and acute abdominal pain
are presenting signs of acute pancreatitis, cholangiohepatitis,
and hepatic abscess [8, 9]. Fever may be present with
infectious causesof hepatic injury such asleptospirosis, ICH,
bacterial cholangiohepatitis, liver abscess, systemic mycoses,
and extrahepatic infections [8].
3.4.3.LaboratoryEvaluation. Aninﬂammatory CBCin acute
hepatic failure may suggest acute pancreatitis or underlying
infectious disease. The clinicopathologic test results are
typical of mild, moderate, or severe hepatocellular damage,
suggested by high-serum ALT activity and variable increases
in ALP activity [8]. Other potential ﬁndings include hyper-
bilirubinemia, increased SBA concentration, hypoglycaemia,
hyperammonemia, and coagulopathy. Biochemical evidence
of concomitant renal failure may be present in acute
hepatic failure as sequel to exposure to hepatotoxins (e.g.,
thiacetarsamide and inhalation anesthetics) and infectious
agents (e.g., leptospirosis) [9].
3.4.4.RadiographicFeatures. Radiographicexaminationmay
be unremarkable or may reveal hepatomegaly. Massive
hepatic necrosis causing hepatic parenchymal collapse and
radiographic appreciation of microhepatica although possi-
ble is less consistent with acute hepatic injury [9].
3.4.5. Ultrasonographic Features. Acute hepatic failure may
be characterized by hepatomegaly with normal, increased
or decreased parenchymal echogenicity along with diﬀuse
parenchymal abnormalities wherein the discrete hepatic
borders are not visualized [22]. The hepatic parenchymal
echogenicity in canines with acute hepatic failure may range
from normal to diﬀusely mottled to decreased echogenicity
[23]. Passive congestion observed in acute hepatic insult
is the most common benign cause of diﬀuse decreased
liver echogenicity which result from dilatation of hepatic
sinusoids and hepatitis, owing to swelling of hepatocytes
[24]( Figure 22). Symmetrical changes in hepatic volume in
hepatomegaly can be estimated by measuring the maximal
distance from the caudal tip of the liver on the ventral
midline till the diaphragm. On a sagittal image, there is an
approximately linear relationship between this dimension
and body weight [25] .L a r g el i v e rl o b e si nh e p a t o m e g a l yi n
acute hepatic insults often have rounded margins, whereas
the normal liver lobes have sharp edges [26]. The diﬀuse
hypoechoic hepatic parenchyma and rounded liver margins
Figure 22: Transverse sonogram (2D) of right medial liver lobe
of two and half-year-old intact female Pointer dog depicting
generalized hyperechoic parenchyma with biliary sludge in gall
bladder.
Figure 23: Two-dimensional ultrasonographic appearance of liver
in sagittal scan depicting hyperechoic parenchyma with rounding
of liver lobe surrounded with textured ﬂuid in a 6-year-old male
Labrador Retriever aﬀected with infectious peritonitis.
with hepatomegaly have been documented in acute hepatic
failure as varied sonographic ﬁndings ranging from normal
to diﬀusely mottled or decreased echogenicity [23, 26]
(Figure 23).
3.4.6. Histopathological Features. Diﬀuse hepatic necrosis
is the primary histologic lesion most consistently associ-
ated with acute hepatic failure [8]. Histopathologic lesions
described thus far in acute-to-subacute drug-induced hep-
atopathy in canines are centrilobular necrosis or periportal
inﬂammation, either of which can be features of other
hepatopathies [9].
3.5. Biliary Tract Disorders. Disorders of biliary tract com-
prise of the diseases of the biliary tract itself (e.g., bacterial
cholecystitis,cholangitis,cholangiohepatitis,andnecrotizing
cholecystitis)andextrahepaticbileductobstruction(EBDO)
in canines.
3.5.1. Etiology. Bacterial cholecystitis is most commonly
caused by aerobic gram-negative bacteria (especially E. coli,
Klebsiella, Pseudomonas,a n dSalmonella spp) or anaerobes
(Clostridium spp). Cholelithiasis can predispose to chole-
cystitis by obstructing the cystic duct, causing gallblad-
der overdistension and stasis, which enables proliferation10 Veterinary Medicine International
of anaerobic organisms [8]. The cause of spontaneous
cholelithiasis, although cannot be determined, requires
initial nidus formation, retention of particles in the gall
bladder, and then sustained growth of the cholelith [9].
The extrahepatic bile duct obstruction may be the result
of extraluminal compressive causes (e.g., neoplasia, stric-
ture, diaphragmatic hernia, and congenital anomalies of
the extrahepatic biliary tract) and intraluminal obstructive
causes (e.g., cholelithiasis, inspissated bile, and liver ﬂukes)
[27]. Cholangiohepatitis and cholecystitis is most commonly
associated with ascending infection [1]. Cholecystitis as
generalized gall bladder wall thickening is associated with
acute pyelonephritis, portal hypertension, chronic renal
diseases, and hepatitis [24]. Biliary sludge which is regarded
as a precursor of cholecystolithiasis in humans is frequently
identiﬁed as an incidental ﬁnding in canines, and its cause
and clinical signiﬁcance are not fully understood [28, 29].
3.5.2. Clinical Manifestations. In cholecystitis, the clinical
signs include anorexia, lethargy, fever, abdominal pain,
vomiting, diarrhoea, and septic shock due to septic bile
peritonitis following acute rupture of gall bladder. Dogs
with cholelithiasis are often asymptomatic and clinical signs
(jaundice, anorexia, weight loss, vomiting, and dehydration)
aremostlikelywhencholelithiasisiscomplicatedbybacterial
infection, EBDO, perforation of the gall bladder or bile
ducts [8]. Regardless of the underlying disorder, typical
clinical signs with biliary obstruction are jaundice, acute or
chronic vomiting, anorexia, depression, weight loss, diar-
rhoea, acholic faeces, excessive bleeding, and occasionally
vague cranial abdominal pain [9]. Physical examination
ﬁndings may show fever, cranial abdominal discomfort,
jaundice, hepatomegaly due to bile engorgement, abdominal
distension, and shock. Excessive bleeding and acholic faeces
are indicative of chronic and complete common bile duct
obstruction [9].
3.5.3. Laboratory Evaluation. On the CBC, a mild neu-
trophilia and mild nonregenerative anaemia are common.
Neutrophilia with left shift suggests the possibility of acute
pancreatitis or abscess, bacterial cholangitis/cholecystitis,
or biliary rupture [8, 9]. Serum chemistry ﬁndings reveal
markedlyincreasedactivityofALPandGGT,cholesterol,bile
acids, and bilirubin. Urinalysis ﬁndings reveal bilirubinuria
andabsenceofurobilinogen.WithvitaminKmalabsorption,
ﬁndings include prolonged PT, APTT, and activated clotting
time.
3.5.4. Radiographic Features. Radiographic ﬁndings depend
on the underlying cause of obstruction and may include
cholelithiasis with radiopaque densities in the area of gall
bladder or bile duct, emphysematous cholecystitis, pancre-
atitis,andmasslesion[8].Microhepaticamaybeappreciated
radiographically with chronic biliary obstruction in dog
leads to biliary cirrhosis [8, 9]. There may be complete
loss of abdominal detail with septic bile peritonitis [9].
Choleliths may be radiographically recognized as discrete
rounded radiopacities in the cranial right ventral shadow.
Figure 24: Hepatic sonogram (2D) in sagittal scan of a ﬁve-year-
old intact Pomeranian male dog depicting increased parenchymal
echogenicity with hyperechoic double rim appearance of GB wall.
3.5.5. Ultrasonographic Features. The gall bladder wall,
owing to cholecystitis gives thickened appearance due to
visualization of both the inner and outer walls and is
perceived as double rim eﬀect [30]. Double rim eﬀect of
gall bladder wall in cholecystitis has also been reported [26].
A hyperechoic thickened GB wall with echogenic bile and
biliary sludge were the features associated with cholecystitis
[31]. Cholecystitis is sonographically characterized by a
hyperechoic gall bladder wall with thickness more or equal
to 3mm [32] and may have thickness of more than 4mm in
casesof neoplasia [33] (Figures24 and 25). Incholecystitis of
inﬂammatory origin, the thickened gall bladder wall may be
isoechogenic with hepatic parenchyma [33].
The choleliths have been observed as echogenic/
hyperechoic foci within the dependent lumen of the gall
bladder, with some degree of acoustic shadowing [16, 34]
(Figure 26).
3.5.6. Histopathological Features. Histopathologic changes in
the gall bladder, bile ducts, and liver may be absent with
uncomplicated cholelithiasis. However, mild cholangitis and
cholecystitis are common [8].
3.6. Hepatobiliary Neoplasia
3.6.1. Etiology. The cause of naturally occurring primary
hepatic neoplasms in dog is unknown. The possible causes
of focal hepatic enlargement include cysts, granulomas,
abscesses, neoplasia, regenerative nodules, haematomas, and
rarely liver lobe torsion [7]. Noncystic cavitary lesions have
been described as mixed areas of anechoic, hypoechoic
and hyperechoic patterns resulting from neoplasia [35].
These noncystic cavitary lesions may also result from
acquired collections of blood, necrotic ﬂuid, or cellular
debris contained within hematomas, nodular hyperplasia, or
large neoplastic masses [36]. Invasiveness of hepatocellular
carcinomaandcholangiocellularcarcinomawiththeirradio-
graphic appreciation as hepatomegaly has been reported
[7], whereas inﬂammatory diseases or neoplasia, hepatic
venous congestion, fat inﬁltration, cholestasis, cirrhosis,
inﬁltrative diseases (amyloidosis or lipidosis), and storage
diseaseshavebeendescribedasthepotentialcausesofdiﬀuseVeterinary Medicine International 11
Figure 25: Two-dimensional ultrasonographic appearance in sagit-
tal scan of cirrhosed liver lobe in a seven-year-old intact mixed-
breed dog depicting collapsed and irregularly shaped gall bladder
with echogenic and thickened (4 mm) GB wall.
Figure 26: Longitudinal sonogram (2D) of liver of two and
half-year-old, intact female Pointer dog showing cholecystitis as
echogenic thickened GB wall and mineralization in the neck
of gall bladder with acoustic shadowing along with hyperechoic
parenchyma.
hepatomegaly [11]. Hepatic neoplasia can lead to symmetric
hepatomegaly in 25% of the aﬀected dogs [37].
3.6.2. Clinical Manifestations. The most consistent signs are
anorexia, lethargy, weight loss, vomiting, abdominal disten-
sion, polyuria/polydipsia, jaundice, diarrhoea, and excessive
bleeding. The potential ﬁndings in hepatobiliary neoplasia
may include a cranial abdominal mass and hepatomegaly
with hepatodynia, pallor, jaundice, and cachexia [8, 9]
(Figure 27).
3.6.3. Laboratory Evaluation. Potential haematologic ﬁnd-
ings with hepatic neoplasia include anaemia (nonregener-
ative/regenerative) and leucocytosis, whereas biochemical
ﬁndings may be variable and nonspeciﬁc for liver disease
[9]. Increases in ALT and ALP usually are mild to marked
but may be normal, especially with metastatic tumours
[8]. Other ﬁndings include hyperbilirubinemia, hypoalbu-
minaemia, hyperglobulinaemia, increased SBA concentra-
tion, prolonged BSP dye retention, and abnormal coagula-
tion tests [9].
3.6.4.RadiographicFeatures. Theirregularhepaticsilhouette
has been documented as a radiographic feature of nodular
Figure 27: Cranial abdominal discomfort exhibited by a nine-year-
old spayed female German Shepherd Dog with hepatic and splenic
mass by assuming “position of relief.”
Figure 28: Right lateral radiograph of a nine-year-old spayed
female, German shepherd dog revealing hepatic nodular masses
on the caudal visceral margins of right liver lobes irregular.
Visualization was enhanced by the negative contrast provided by air
in gastric fundus.
hyperplasia [7], whereas focal hepatic enlargement can be
detected by bulge or alteration in the hepatic margin or the
localized displacement of the fundus, gastric body, pylorus,
right kidney, cranial duodenal ﬂexure, transverse colon, and
headofthespleenordiaphragm[16].Liverlobeenlargement
displaces the body and pyloric regions of the stomach
dorsally and to the left [38]( Figure 28).
Severe diﬀuse hepatomegaly can be easily demonstrated
on lateral radiographic projections as substantial portion
of the caudal liver margin projecting beyond the costal
arch along with rounding of the caudal liver edges. It
may also be evidenced by caudodorsal displacement of
stomach in lateral projection and caudally towards the
left in ventrodorsal projections [7]. Hepatomegaly can be
radiographicallyevidencedasincreaseddistancebetween the
stomach and diaphragm or caudal displacement and ventral
covering of the right kidney by the liver [39]. Hepatomegaly
is reliable radiographic sign of liver disease which may be
diﬀuse, with uniform enlargement of all lobes or focal, with
enlargement of only a single lobe [11]( Figure 29).
3.6.5. Sonographic Features. Focal nodular hyperplasia
lesions have been documented as well deﬁned solid masses
having a variable, often greater echogenicity than the normal12 Veterinary Medicine International
Figure 29: Lateral abdominal radiograph of an 8-year-old intact
male, mixed-breed dog with cutaneous tumour and pulmonary
metastasis demonstrating generalized hepatomegaly.
Figure 30: Transverse ultrasonogram (2D) of liver in a nine-year-
old spayed female, German shepherd dog revealing two hypere-
choic homogenous circular nodular masses measuring 55mm and
29mm.
liver parenchyma, and a central highly echogenic area.
Hepatic lymphosarcoma may be sonographically character-
ized as a diﬀuse, decreased or increased echogenicity in
an o r m a lt oe n l a r g e dl i v e r[ 40]. Hepatic lymphosarcoma
may also be observed as multifocal poorly circumscribed
hypoechoic areas or well-circumscribed hypoechoic nod-
ules surrounded by areas of hyperechogenicity (target
lesions) [41]. Hepatic lymphoma has been sonographically
characterized by decreased hepatic echogenicity in canines
[22], whereas a solitary hyperechoic mass has been de-
scribed as the most common appearance of canine hepat-
ocellular carcinoma [42]. Primary hepatic neoplasia has a
variable sonographic appearance ranging from a very large,
moderately circumscribed, inﬁltrating mass bulging beyond
the normal liver margins with an echogenicity slightly more
mixed than normal liver [43]. Ultrasonography is sensitive
in the detection of small focal lesions, although lesions less
than 2cm are hard to identify with this imaging modality. It
is also not so useful if the lesion is less than 2cm in diameter
and isoechoic with normal tissue [24] (Figures 30, 31,a n d
32).
Noncystic cavitary lesions (e.g., abscesses, hematomas,
hepatic nodular hyperplasia, and cavitated neoplasms) have
been documented as mixed or complex echoic structures
Figure 31: Sagittal sonogram (2D) of liver in a ten-year-old intact
Labrador retriever dog aﬀected by a perianal tumour showing
hyperechoic hepatic mass with central lytic changes.
Figure 32: Two-dimensional ultrasonographic transverse scan in
a ﬁve-year-old intact mixed-breed dog showing an encapsulated
hypoechoic hepatic mass with irregular margins.
with either well- or poorly deﬁned borders [36]. Irregular,
poorly deﬁned borders in such lesions result in edge
shadowing that is less apparent than that occurring from
well-deﬁned cysts (Figures 33, 34,a n d35).
3.6.6. Laparoscopic Features. Laparoscopy provides advan-
tage of direct visualization and extracting valuable informa-
tion regarding the conditions of the tissues and the extension
of the lesions while visualizing hepatic tumours, hep-
atic necrosis, splenic and pancreatic atrophy, hepatofrenic
adhesion, intestinal neoplasia, and piometritis [44]. The
diagnostic precision of laparoscopy is tremendous, and it can
easily visualize metastatic lesions/masses as small as 0.5cm
or less, which are not observed easily by other diagnostic
techniques [3]( Figure 36).
3.6.7. Histopathologic Features. The most common types of
primary hepatic cancer reported in male dogs are hepato-
cellular carcinoma and intrahepatic cholangiocellular (bile
duct)carcinomainfemaledogs. Hepatocellularadenomaare
observed less frequently in either gender [9]. Metastases to
the liver by hematogenous routes from distant sites are much
more common, arising from gastrointestinal, pancreatic and
mammaryadenocarcinomaandfromhemangiosarcoma[9].Veterinary Medicine International 13
Figure 33:Sagittalsonograph(2D)ofliverwithextensivenoncystic
cavitary lesions in hepatic parenchyma in a nine-year-old intact
male Boxer dog.
Figure 34: Two-dimensional ultrasonographic sagittal scan of right
liver lobe in seven-year-old mixed-breed intact male dog showing
noncystic cavitary lesions with generalized increase in parenchymal
echogenicity.
Liver involvement is also common in canines with lym-
phoma.
4. Conclusion
As the liver is physiologically and anatomically diverse, there
is no single test that adequately identiﬁes hepatic disease or
its underlying cause. For this reason, a battery of tests must
beusedtodiagnosethehepatobiliaryaﬀections.Areasonable
package of screening tests recommended for an animal
suspectedofhavinghepatobiliarydiseaseincludesacomplete
blood count (CBC), serum biochemical proﬁle, urinalysis,
faecal analysis, survey radiography, and ultrasonography.
The primary indication so obtained may suggest evidence
of hepatobiliary disease that can be conﬁrmed by other,
more speciﬁc tests including advanced diagnostic imaging
procedures. The need for other laboratory tests, that is,
abdominocentesis, coagulation proﬁle, and evaluation of
fastingplasmaammoniaconcentration,andsoforthisdeter-
mined by each animal’s history and physical examination
ﬁndings. A deﬁnitive diagnosis of hepatobiliary aﬀection
shouldbe conﬁrmedbyhepatic biopsy and histopathological
examination.
Figure 35: Ultrasonogram (2D) of liver in longitudinal scan
revealing large poorly echogenic area with internal septations in a
one and half-year-old neutered male Doberman pinscher dog.
Figure 36: Laparoscopic direct visualization of liver in 5-year-
old mixed-breed male dog showing a nodular hyperplasia which
remained undetected ultrasonographically.
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